Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 186
1
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Bridging International Borders to Fight Re-emerging Plague in Madagascar

The Plague is considered one of the most successful infectious agents in history and at one point killed nearly...

Understanding the perspective of women who use the Billings Ovulation Method

Fertility awareness-based methods (FABM) are a group of family planning methods that teach women how to identify...

Backer Badge Funded